Showing results (251-260 of 291) with videos related to
Sort By:
Pageof 30
Gene Therapy|March 9, 2021
Mesenchymal stem cells overexpressing BMP-9 by CRISPR-Cas9 present high in vitro osteogenic potential and enhance in vivo bone formationGileade P Freitas, Helena B Lopes, Alann T P Souza, et al.Oncotarget|May 26, 2016
The BRG1 chromatin remodeling enzyme links cancer cell metabolism and proliferationQiong Wu, Pasil Madany, Jason R Dobson, et al.Journal of Cellular Biochemistry|July 11, 2008
Genetic and epigenetic regulation in nuclear microenvironments for biological control in cancerGary S Stein, Sayyed K Zaidi, Janet L Stein, et al.Advances in Biological Regulation|May 16, 2018
Nuclear organization mediates cancer-compromised genetic and epigenetic controlSayyed K Zaidi, Andrew J Fritz, Kirsten M Tracy, et al.Annals of the New York Academy of Sciences|March 3, 2009
Organization, integration, and assembly of genetic and epigenetic regulatory machinery in nuclear microenvironments: implications for biological control in cancerGary S Stein, Sayyed K Zaidi, Janet L Stein, et al.Genome Biology|September 30, 2015
Chromatin interaction analysis reveals changes in small chromosome and telomere clustering between epithelial and breast cancer cellsA Rasim Barutcu, Bryan R Lajoie, Rachel P McCord, et al.Gene|November 30, 2005
The bone-related Zn finger transcription factor Osterix promotes proliferation of mesenchymal cellsYeon-Ju Kim, Hyun-Nam Kim, Eui-Kyun Park, et al.Molecular Cancer Therapeutics|December 17, 2010
The histone deacetylase inhibitor, vorinostat, reduces tumor growth at the metastatic bone site and associated osteolysis, but promotes normal bone lossJitesh Pratap, Jacqueline Akech, John J Wixted, et al.Journal of Cellular Physiology|July 19, 2008
Expression of Runx2 transcription factor in non-skeletal tissues, sperm and brainJae-Hwan Jeong, Jung-Sook Jin, Hyun-Nam Kim, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 11, 2016
MicroRNA-378-mediated suppression of Runx1 alleviates the aggressive phenotype of triple-negative MDA-MB-231 human breast cancer cellsGillian Browne, Julie A Dragon, Deli Hong, et al.Pageof 30